| In
a closer look at the results of a study aimed at improving the
treatment of acute myocardial infarction (AMI) patients, the
improvements in treatment of women and Medicare patients was
greater than it was in men and non-Medicare patients.
At
an ACC'02 press conference on March 19, Rajendra H. Mehta,
MD, from the University of Michigan Medical Center, reported
that improvements in adherence to key quality indicators such
as aspirin and beta blocker administration at admittance and
smoking cessation counseling at discharge were markedly higher
in both women and Medicare patients when compared to men and
non-Medicare patients. In general, there were improvements
in quality indicator adherence for all four patient populations.
The
study in Michigan is part of the American College of Cardiology
Foundations (ACCF) Guidelines Applied in Practice (GAP)
initiative. The initial results of the study were published
on March 13 in the Journal of the American Medical Association
(JAMA).
In
the study, medical staff at 10 southeastern Michigan hospitals
used a tool kitincluding a pocket clinical
practice guideline, standard order sets, and a critical pathway
for nursesto help them adhere to key quality indicators
in the care of AMI patients. The results published in JAMA
showed, for example, that before implementation of GAP in
the hospitals, only 65 percent of heart attack patients received
beta blockers within 24 hours of arriving at the hospital;
afterward, that figure rose to 74 percent. Similarly, the
percentage of patients receiving aspirin within 24 hours of
admittance rose from 81 percent to 87 percent.
The
analysis presented on Tuesday was particularly important,
Dr. Mehta stressed, because the quality of care of AMI
in women and the elderly has been suboptimal.
Early
use of ACE inhibitors in non-Medicare patients in the study
increased from 35 percent to 42.2 percent. In Medicare patients,
however, early ACE inhibitor usage increased from 33.7 percent
to 43.7 percent. Similar results with important quality indicators
were seen across the board. With beta blocker administration
at discharge, for example, there was an increase in male patients
from 90.1 percent to 92.5 percent. In female patients, beta
blocker usage at discharge was 85.7 percent before implementation
of GAP and 93.9 percent afterwards.
Given
the promising results of the study, Dr. Mehta encouraged hospitals
to consider implementing a GAP program in their own facilities.
More information about the ACCF-GAP program is available on
the Colleges Web site.
The GAP tools for heart attack treatment may be downloaded
at no cost from http://www.acc.org/gap/mi/ami_gap.htm.
|